Food « Weekly Sauce

FDA Removes Top Expert on Vaping and Tobacco

The U.S. Food and Drug Administration’s (FDA) top tobacco regulator, Brian King, has been placed on leave as part of a large wave of cuts across federal health agencies. King, who led the FDA’s tobacco control efforts, told his staff Tuesday that he was removed with “a heavy heart and profound disappointment.” “If you make… read on > read on >

Zepbound Now Available Through Hims & Hers

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform. The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. Zepbound is made by drugmaker Eli Lilly. While Hims & Hers offers it… read on > read on >

Low ‘Bad’ Cholesterol Might Protect Against Dementia, Alzheimer’s

Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with low-density lipoprotein (LDL) cholesterol levels lower than 70 mg/dl had a 26% lower risk of dementia and 28% lower risk of Alzheimer’s, compared to people with LDL levels above 130 mg/dl, researchers reported… read on > read on >

Fasting Outperforms Calorie Cutting, Clinical Trial Says

Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows. People who undertook 4:3 intermittent fasting lost just under 8% of their body weight within a year, compared to a 5% loss among people who cut their daily calories by about a third, researchers reported March 31… read on > read on >

FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors

Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placebo read on >

Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation

A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions. Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said he will resign and retire by April 5. In a letter to the acting FDA… read on > read on >

Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placebo read on >

Experts say move could negatively impact oral health, especially among children and low-income communities read on >

As a measles outbreak spreads across the United States, doctors are now seeing a new and unexpected danger: Children getting sick from taking too much vitamin A. At Covenant Children’s Hospital in Lubbock, Texas, several unvaccinated children showed signs of liver problems after taking large amounts of vitamin A, according to Dr. Lara Johnson, the… read on > read on >

Splenda doesn’t directly add calories to your diet, but the sweetener still might lead people to pack on pounds, a new study says. The sugar substitute might spur on a person’s appetite and feelings of hunger, potentially leading them to overeat, according to results published March 26 in the journal Nature Metabolism. Splenda’s main ingredient,… read on > read on >

A mom’s health and lifestyle choices can affect her kids’ risk of obesity as adults, a new study says. Specifically, a child is 3 to 4 times more likely to become an obese adult if their mom was obese, researchers reported March 26 in PLOS One. A mom’s smoking also increased their kid’s risk of… read on > read on >

Artificial intelligence (AI) can help improve how premature babies are fed, giving them a better chance at normal growth and development, a new study says. Currently, preemies in a neonatal intensive care unit are fed by IV, receiving a drip-drop handmade blend of nutrients that doctors call total parenteral nutrition, or TPN. This is the… read on > read on >

Medication approved for uUTIs in women and pediatric patients aged 12 years and older read on >

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co., a Chinese pharmaceutical company. Novo Nordisk will pay $200 million up front,… read on > read on >

Statins are very cheap and highly effective cholesterol-lowering drugs — but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, according to findings published March 23 in Mayo Clinic Proceedings. Using a high-dose… read on > read on >